MyAverix Finance
F · Healthcare
Cybin Inc. (R7E)
Biotechnology
Cybin Inc. (R7E) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $187.60M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R7E
Cybin Inc. (R7E) — FAQ
What is Cybin Inc.'s market cap?
Cybin Inc. (R7E) has a reported market cap of $187.60M (data as of 2026-03-30).
What is R7E's P/E ratio?
The price-to-earnings (P/E) ratio for Cybin Inc. (R7E) is 18.00 (data as of 2026-03-30).
Does Cybin Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Cybin Inc. (R7E). Check the MyAverix Finance app for the latest dividend data.
What sector is Cybin Inc. in?
Cybin Inc. (R7E) is classified in the Healthcare sector (Biotechnology industry).
What exchange is R7E listed on?
R7E is listed on F.
What is Cybin Inc.'s net margin?
Cybin Inc. (R7E) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.